论文部分内容阅读
目的探讨低分子肝素对大鼠百草枯中毒致肺纤维化的作用及可能的机制。方法采用百草枯(40 mg/kg)灌胃方法建立中毒模型,将54只SD大鼠随机分为健康对照组、百草枯中毒组(中毒组)、低分子肝素治疗组(治疗组),治疗组每只大鼠于百草枯灌胃后30 min皮下注射1 000 U/kg的低分子肝素钠,分别于第7、14和28天检测血清转化生化因子β1(TGF-β1)、Ⅲ型前胶原肽(PⅢP)、羟脯氨酸(HYP),并观察各时间点肺组织病理改变。结果与对照组比较,中毒组及治疗组在第7、14和28天TGF-β1、PⅢP、HYP均明显升高(P<0.05);与中毒组比较,治疗组在第7、14、28天TGF-β1、PⅢP、HYP水平较中毒组明显下降(P<0.05)。肺组织病理学发现,给予百草枯染毒后,大鼠肺纤维化程度随时间的延长逐渐加重,间质中成纤维细胞逐渐增多,胶原沉积逐渐增加,肺泡结构破坏逐渐加重;给予低分子肝素治疗后,大鼠肺泡结构破坏减少,间质中成纤维细胞及胶原沉积减少。结论低分子肝素可以通过减少TGF-β1、PⅢP、HYP的生成,减轻百草枯致肺纤维化的程度。
Objective To investigate the effect and possible mechanism of low molecular weight heparin on pulmonary fibrosis induced by paraquat poisoning in rats. Methods The poisoning model was established by intragastric administration of paraquat (40 mg / kg). 54 SD rats were randomly divided into healthy control group, paraquat poisoning group (poisoning group) and low molecular weight heparin treatment group (treatment group) Group Rats were injected subcutaneously with 1 000 U / kg low molecular weight heparin 30 min after intragastric administration of paraquat. Serum levels of transforming growth factor β1 (TGF-β1), pre-Ⅲ Collagen peptide (PⅢP), hydroxyproline (HYP), and observe the pathological changes of lung tissue at different time points. Results Compared with the control group, the levels of TGF-β1, PⅢP and HYP were significantly increased on the 7th, 14th and 28th days in the poisoned and untreated groups (P <0.05). Compared with the poisoned group, The levels of TGF-β1, PⅢP and HYP were significantly lower than those of the poisoning group (P <0.05). Lung histopathology showed that after paraquat poisoning, the degree of pulmonary fibrosis in rats gradually increased with the extension of time, interstitial fibroblasts gradually increased, collagen deposition increased gradually, alveolar structure destruction gradually aggravated; given low molecular weight heparin After treatment, the destruction of alveolar structure in rats decreased, interstitial fibroblasts and collagen deposition decreased. Conclusion Low molecular weight heparin can reduce paraquat-induced pulmonary fibrosis by reducing the production of TGF-β1, PⅢP and HYP.